Free Trial

Applied Therapeutics (APLT) Competitors

$5.27
+0.20 (+3.94%)
(As of 06/12/2024 ET)

APLT vs. CDMO, RIGL, PBYI, GTHX, PRTA, INDV, BHC, JANX, DCPH, and AMRX

Should you be buying Applied Therapeutics stock or one of its competitors? The main competitors of Applied Therapeutics include Avid Bioservices (CDMO), Rigel Pharmaceuticals (RIGL), Puma Biotechnology (PBYI), G1 Therapeutics (GTHX), Prothena (PRTA), Indivior (INDV), Bausch Health Companies (BHC), Janux Therapeutics (JANX), Deciphera Pharmaceuticals (DCPH), and Amneal Pharmaceuticals (AMRX). These companies are all part of the "pharmaceutical preparations" industry.

Applied Therapeutics vs.

Applied Therapeutics (NASDAQ:APLT) and Avid Bioservices (NASDAQ:CDMO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk, institutional ownership and community ranking.

Applied Therapeutics has a beta of 1.88, meaning that its share price is 88% more volatile than the S&P 500. Comparatively, Avid Bioservices has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500.

Avid Bioservices has higher revenue and earnings than Applied Therapeutics. Avid Bioservices is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied Therapeutics-$477K-1,262.45-$119.76M-$1.84-2.86
Avid Bioservices$149.27M3.24$260K-$0.27-28.18

Avid Bioservices received 296 more outperform votes than Applied Therapeutics when rated by MarketBeat users. Likewise, 66.49% of users gave Avid Bioservices an outperform vote while only 56.35% of users gave Applied Therapeutics an outperform vote.

CompanyUnderperformOutperform
Applied TherapeuticsOutperform Votes
71
56.35%
Underperform Votes
55
43.65%
Avid BioservicesOutperform Votes
367
66.49%
Underperform Votes
185
33.51%

In the previous week, Applied Therapeutics had 12 more articles in the media than Avid Bioservices. MarketBeat recorded 14 mentions for Applied Therapeutics and 2 mentions for Avid Bioservices. Avid Bioservices' average media sentiment score of 1.88 beat Applied Therapeutics' score of 0.41 indicating that Avid Bioservices is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Applied Therapeutics
5 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Avid Bioservices
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Applied Therapeutics has a net margin of 0.00% compared to Avid Bioservices' net margin of -13.10%. Avid Bioservices' return on equity of -8.78% beat Applied Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Applied TherapeuticsN/A -1,497.37% -176.54%
Avid Bioservices -13.10%-8.78%-3.61%

Applied Therapeutics currently has a consensus price target of $11.00, suggesting a potential upside of 108.73%. Avid Bioservices has a consensus price target of $14.50, suggesting a potential upside of 90.54%. Given Applied Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Applied Therapeutics is more favorable than Avid Bioservices.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Applied Therapeutics
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Avid Bioservices
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

98.3% of Applied Therapeutics shares are owned by institutional investors. Comparatively, 97.2% of Avid Bioservices shares are owned by institutional investors. 8.6% of Applied Therapeutics shares are owned by company insiders. Comparatively, 2.4% of Avid Bioservices shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Applied Therapeutics and Avid Bioservices tied by winning 9 of the 18 factors compared between the two stocks.

Get Applied Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APLT vs. The Competition

MetricApplied TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$602.19M$7.33B$5.32B$8.38B
Dividend YieldN/A2.65%2.83%4.06%
P/E Ratio-2.8622.16180.3318.41
Price / Sales-1,262.45281.212,270.2574.90
Price / CashN/A32.7634.4630.83
Price / Book-26.355.624.954.32
Net Income-$119.76M$147.13M$110.10M$215.94M
7 Day Performance17.11%-0.78%-0.12%-0.06%
1 Month Performance18.96%0.35%0.47%0.03%
1 Year Performance263.45%-5.56%1.22%2.89%

Applied Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDMO
Avid Bioservices
3.6258 of 5 stars
$8.17
+2.3%
$14.50
+77.5%
-55.1%$518.63M$149.27M-30.26365Upcoming Earnings
Positive News
Gap Up
RIGL
Rigel Pharmaceuticals
2.7711 of 5 stars
$1.02
-0.5%
$5.81
+472.7%
-39.4%$178.04M$116.88M-8.46147Positive News
PBYI
Puma Biotechnology
4.047 of 5 stars
$3.45
-0.6%
$7.00
+102.9%
+3.9%$166.43M$235.60M10.45185Analyst Upgrade
Short Interest ↓
Gap Up
GTHX
G1 Therapeutics
3.3056 of 5 stars
$2.93
+2.1%
$8.67
+195.8%
+6.3%$153.18M$84.04M-4.73100Analyst Forecast
Short Interest ↑
Gap Up
PRTA
Prothena
1.5697 of 5 stars
$21.25
+3.7%
$67.00
+215.3%
-70.6%$1.14B$91.37M-6.54173Gap Up
INDV
Indivior
3.5079 of 5 stars
$16.97
+0.6%
$36.00
+112.1%
N/A$2.34B$1.09B1,697.001,164Short Interest ↓
BHC
Bausch Health Companies
4.3493 of 5 stars
$6.27
+2.8%
$11.33
+80.8%
-13.4%$2.30B$8.76B-5.0620,270Short Interest ↓
Gap Up
JANX
Janux Therapeutics
2.8965 of 5 stars
$43.83
+4.3%
$66.29
+51.2%
+229.1%$2.27B$8.08M-35.9368Gap Up
DCPH
Deciphera Pharmaceuticals
3.3563 of 5 stars
$25.59
flat
$24.17
-5.5%
N/A$2.21B$163.36M-11.58355Short Interest ↓
Positive News
AMRX
Amneal Pharmaceuticals
1.1071 of 5 stars
$7.11
+1.1%
$8.25
+16.0%
+182.1%$2.19B$2.39B-12.707,700Short Interest ↑
Gap Up

Related Companies and Tools

This page (NASDAQ:APLT) was last updated on 6/13/2024 by MarketBeat.com Staff

From Our Partners